Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. Lepu Medical is specialized in developing, manufacturing and distributing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and intensive care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, cardiac in vitro diagnosis products, anesthetic products, angiography systems and surgical staplers. In 2009, Lepu Medical successfully listed on ChiNext Shenzhen Stock Exchange market (stock code: 300003) with the market value of 10 billion USD. Now Lepu Medical totally has 28 primary subsidiary companies worldwide. There are more than 60 products have received the CE certificates, and 6 products have got the FDA approvals. As the National Interventional Cardiology Medical Instruments & Engineering Technology Research Center, Lepu Medical Group’s top strategy is to build up a 4 in 1 platform includes medical device, pharmaceutical, Healthcare Service, Mobile Medical. Currently, Lepu Medical has established three overseas subsidiary companies in Netherland, Turkey and India, obtained local registrations in 27 countries, and built the sales and distribution channels in over 80 countries and regions. Lepu Medical upholds “integrity, quality and scientific innovation” as its spirit, commitments to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.